Arvelle Therapeutics
Healthcare
HQ: Zug, Switzerland
Investors: 1
Arvelle Therapeutics is a biopharmaceutical company bringing innovative solutions to patients suffering from CNS disorders.
Investors (1)
| Fund | Status | Entry Date | Stage | Source |
|---|---|---|---|---|
| H.I.G. Capital | Exited | - | - | Website |
Get these signals delivered weekly
Deals, exits, fundraises, and key hires from funds active in Italy — straight to your inbox.
Get Signals